It is a relationship that we are proud of. At the core of the relationship is sharing knowledge to improve outcomes for patients. We want to ensure that patients and others have confidence that this relationship is open and transparent and this is why the pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by industry to HCPs and HCOs.
This information will be published on the database - Disclosure UK.
Disclosure UK is part of a Europe-wide initiative to increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals and organisations it works with.
Please note: the Disclosure UK database does not currently work in Edge. Please search using Chrome, Internet Explorer, Firefox or Safari.
Disclosure UK update 27 November, 2020
All 2019 disclosure information has been published on Disclosure UK as normal. For information on why the disclosure process was temporary changed this year as a result of the pandemic, a technical note is available from the Disclosure UK resources page.
As well as searching Disclosure UK you can also download the full dataset and Methodological Notes to explore the data further.
Disclosure UK is an industry-led initiative to deliver a searchable database that shows payments and benefits in kind made by the pharmaceutical industry to doctors, nurses and other health professionals and organisations in the UK.
The resources on this page are available for use by the pharmaceutical industry, healthcare professionals (HCPs) and healthcare organisations (HCOs) to help them understand how Disclosure UK works.